Tracing the molecular pathogenesis of antiphospholipid syndrome

Journal of Clinical Investigation

Volumn 118, Issue 10, 2008, Pages 3276-3278

  Weiler, Hartmut ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR; FONDAPARINUX; HEPARIN; HIRUDIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN; THROMBOPLASTIN;

ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING; COMPLEMENT ACTIVATION; FETUS WASTAGE; NEUTROPHIL; NONHUMAN; NOTE; PATHOGENESIS; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOSIS;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FETAL DEATH; HUMANS; MICE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RECEPTOR, PAR-2; THROMBOPLASTIN; THROMBOSIS;

EID: 55849139466     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI37243     Document Type: Note

References (20)

1. Salmon, J.E., and de Groot, P.G. 2008. Pathogenic role of antiphospholipid antibodies. Lupus. 17:405-411.
2. de Laat, B., Mertens, K., and de Groot, P.G. 2008. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism. Nat. Clin. Pract. Rheumatol. 4:192-199.
3. Levine, J.S., Branch, D.W., and Rauch, J. 2002. The antiphospholipid syndrome. N. Engl. J. Med. 346:752-763.
4. Salmon, J.E., and Girardi, G. 2008. Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation. J. Reprod. Immunol. 77:51-56.
5. Salmon, J.E., Girardi, G., and Lockshin, M.D. 2007. The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients. Nat. Clin. Pract. Rheumatol. 3:140-147.
6. Holers, V.M., et al. 2002. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J. Exp. Med. 195:211-220.
7. Girardi, G., et al. 2003. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J. Clin. Invest. 112:1644-1654.
8. Berman, J., Girardi, G., and Salmon, J.E. 2005. TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss. J. Immunol. 174:485-490.
9. Redecha, P., et al. 2007. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood. 110:2423-2431.
10. Redecha, P., Franzke, C.-W., Ruf, W., Mackman, N., and Girardi, G. 2008. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome. J. Clin. Invest. 118:3453-3461.
11. Mackman, N. 2004. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler. Thromb. Vasc. Biol. 24:1015-1022.
12. Versteeg, H.H., and Ruf, W. 2007. Tissue factor coagulant function is enhanced by protein-disulfide isomerase independent of oxidoreductase activity. J. Biol. Chem. 282:25416-25424.
13. Atkinson, J.P. 2003. Complement system on the attack in autoimmunity. J. Clin. Invest. 112:1639-1641.
14. Girardi, G., Redecha, P., and Salmon, J.E. 2004. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat. Med. 10:1222-1226.
15. Salmon, J.E., and Girardi, G. 2007. Theodore E. Woodward Award: antiphospholipid syndrome revisited: a disorder initiated by inflammation. Trans. Am. Clin. Climatol. Assoc. 118:99-114.
16. Pierangeli, S.S., et al. 2005. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum. 52:2120-2124.
17. Pennings, M.T., et al. 2007. Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2′. J. Thromb. Haemost. 5:369-377.
18. Shi, T., et al. 2006. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. Arthritis Rheum. 54:2558-2567.
19. White, T.C., et al. 2008. Protein C supports platelet binding and activation under flow: role of glycoprotein Ib and apolipoprotein E receptor 2. J. Thromb. Haemost. 6:995-1002.
20. Kassis, J., et al. 2004. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis. Thromb. Haemost. 92:1312-1319.